MRI Scanning to Monitor Mouth Cancer Risk in Fanconi Anemia
Part of Blood & lymphatic, Genetic & congenital, Hormones & metabolism clinical trials.
This study uses MRI (a safe imaging scan) to detect and track dangerous changes in the mouth of people with Fanconi Anemia, a rare genetic condition. The goal is to find a better way to catch oral cancer early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with Fanconi Anemia
- You must be 18 years old or older
- You must be able to lie still in an MRI machine for about 30 minutes
- You cannot have metal implants or devices that conflict with MRI
- You must be able to understand the study and give your permission to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a breakdown product from alcohol (acetaldehyde) may play a role in oral (mouth) cancer. It may help researchers understand who is more affected by alcohol and why.
This study looks at how squamous cell carcinoma (a type of cancer) naturally develops over time in people with Fanconi anemia. It may help doctors better recognize warning signs and plan care in the future.
This study observes and talks with adults with Fanconi anemia about their feelings during cancer screening visits. It aims to learn how to better support people with FA through screening anxiety.
This study tests whether a special MRI machine can take detailed images of teeth and jaws for routine dental care. It may help find problems without using X-rays.
This research study uses MRI imaging and local anesthetic (numbing medicine) to better understand how anesthesia works. You'll receive numbing medication in your mouth area while inside an MRI machine to help doctors improve pain management techniques.
This study uses a safe, non-invasive method to look at mouth growths in people with Fanconi anemia. It aims to better understand these lesions without needing a biopsy.
Hear when a new Fanconi Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.